Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...
Back in 2024, Renesas first released the RA0E1, an ultra-low-power Cortex-M23 MCU designed for cost-sensitive applications, followed by the RA0E2, with ...
Abstract: Wearable systems for the continuous and real-time monitoring of cardiovascular diseases are becoming widespread and valuable assets in diagnosis and therapy. A promising approach for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results